BB, a novel epidermal growth factor receptor inhibitor.
Wheeler
Deric L
DL
Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, Madison, WI 53792, USA. dlwheeler@wisc.edu
Dunn
Emily F
EF
D000814:Aniline Compounds / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D011799:Quinazolines / Q000494:pharmacology*
D000814:Aniline Compounds; D000970:Antineoplastic Agents; C539257:N-(3-bromophenyl)-7-methoxy-6-(3-(3-methoxypyrrolidin-1-yl)propoxy)quinazolin-4-amine; D011799:Quinazolines; D066246:ErbB Receptors